National Guideline Clearinghouse | Empagliflozin in combination therapy for treating type 2 diabetes.

full-text ►

National Guideline Clearinghouse | Empagliflozin in combination therapy for treating type 2 diabetes.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Empagliflozin in combination therapy for treating type 2 diabetes.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Empagliflozin in combination therapy for treating type 2 diabetes. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Mar. 44 p. (Technology appraisal guidance; no. 336).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.